Screener
Monte Rosa Therapeutics, Inc. GLUE Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$43.4M-253% | -$44.5M-195% | -$46.14M— | -$27.08M-13.5% | -$12.3M+59.4% | ||
| $1.91M-10.1% | $2.03M-0.9% | $2.09M+1.3% | $2.1M-0.4% | $2.13M+3.2% | ||
| $5.97M+22.0% | $5.95M+12.3% | $4.31M-3.6% | $4.36M+1.9% | $4.89M+8.7% | ||
| -$44.11M-27.1% | -$37.37M+17.9% | -$43.01M-133% | $100.43M+578% | -$34.72M-25.0% | ||
| $4.72M+179% | $1.87M+17.7% | $767K+319% | $651K+63.2% | $1.7M-16.2% | ||
| -$28.86M— | -$261M-160% | -$65.07M-111% | —— | —— | ||
| $3.21M+780% | $328.34M+2,345,150% | $29.62M+4,772% | $348K+2,220% | $365K-99.6% | ||
| -$69.76M-672% | $29.97M+121% | -$78.46M-180% | —— | -$9.03M— | ||
| -$48.84M-34.1% | -$39.24M+16.7% | -$43.78M-134% | $99.78M+566% | -$36.42M-22.2% |
FAQ
- How much cash does Monte Rosa Therapeutics, Inc. generate?
- Monte Rosa Therapeutics, Inc. (GLUE) generated -$24.1M in operating cash flow over the trailing twelve months.
- What is Monte Rosa Therapeutics, Inc.'s free cash flow?
- After $8.0M of capital expenditures, Monte Rosa Therapeutics, Inc.'s free cash flow was -$32.1M over the trailing twelve months, down 234.5% year over year.
- Where does Monte Rosa Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Monte Rosa Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
